Condensed quinolines as protein kinase modulators

Details for Australian Patent Application No. 2010286691 (hide)

Owner Cylene Pharmaceuticals, Inc.

Inventors Pierre, Fabrice; Haddach, Mustapha; Regan, Collin F.; Ryckman, David M.

Agent Baldwins

Pub. Number AU-A-2010286691

PCT Pub. Number WO2011/025859

Priority 61/289,317 22.12.09 US; 61/237,227 26.08.09 US

Filing date 26 August 2010

Wipo publication date 3 March 2011

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/429 (2006.01) - condensed with heterocyclic ring systems

A61P 35/00 (2006.01) Antineoplastic agents

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

19 April 2012 PCT application entered the National Phase

  PCT publication WO2011/025859 Priority application(s): WO2011/025859

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010286694-Novel pyrrolidine derived beta 3 adrenergic receptor agonists

2010286690-Printed flexible film for food packaging